Brainstorm Cell Therapeutics Stock Investor Sentiment

BCLI Stock  USD 1.41  0.13  8.44%   
Under 62% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
over a week ago at www.macroaxis.com         
Acquisition by Ralph Kern of 35885 shares of Brainstorm Cell subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn Trial at the 2024 Maxim ...
Google News at Macroaxis
over a week ago at news.google.com         
INVESTOR ALERT Potential Recovery for Brainstorm Cell Therapeutics Inc. Investors Affected by Stock ...
Google News at Macroaxis
over a week ago at news.google.com         
StockNews.com Begins Coverage on Brainstorm Cell Therapeutics - Defense World
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Brainstorm Cell Therapeutics Inc. Short Interest Up 21.3 percent in February
news
over two weeks ago at news.google.com         
INVESTOR ALERT Potential Recovery for Brainstorm Cell Therapeutics Inc. Investors Affected by Stock ...
Google News at Macroaxis
over a month ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Reduces Stake in Brainstorm Cell Therapeutics Inc
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Short Interest in Brainstorm Cell Therapeutics Inc. Drops By 47.2
news
over a month ago at thelincolnianonline.com         
Brainstorm Cell Therapeutics Earns Hold Rating from Analysts at StockNews.com
news
over two months ago at news.google.com         
Brainstorm Cell Therapeutics Appeals Nasdaq Delisting - MSN
Google News at Macroaxis
over two months ago at investing.com         
Brainstorm Cell Therapeutics Appeals Nasdaq Delisting
Investing News at Macroaxis
over two months ago at investing.com         
Brainstorm Cell Therapeutics faces Nasdaq delisting
Investing News at Macroaxis
over two months ago at news.google.com         
BrainStorm Cell Therapeutics announces pricing of 4M registered direct offering - MSN
Google News at Macroaxis
over two months ago at thelincolnianonline.com         
Brainstorm Cell Therapeutics Cut to Sell at StockNews.com
news
over two months ago at finance.yahoo.com         
BCLI Plans Coming Together for Phase 3b Trial of NurOwn in ALS
Yahoo News
Far too much social signal, news, headlines, and media speculation about Brainstorm Cell that are available to investors today. That information is available publicly through Brainstorm media outlets and privately through word of mouth or via Brainstorm internal channels. However, regardless of the origin, that massive amount of Brainstorm data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Brainstorm Cell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Brainstorm Cell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Brainstorm Cell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Brainstorm Cell alpha.

Brainstorm Cell Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets